Medistim : Protocol from the General Meeting

Chairman of the Board of Director's Øyvin Anders Brøymer opened the meeting.

1. Approval of notice and power of attorney
2. There were no comments to the notice, the agenda or proxies and these were approved. The meeting was pronounced lawfully called and assembled.
4. Appointment of person to chair the meeting, to sign the protocol, to co-sign the protocol and protocol secretary
5. Øyvin Anders Brøymer was chosen to chair the meeting. Rigmor Blix and Asbjørn Buanes were chosen to sign the minutes together with Øyvin Brøymer. Thomas Jakobsen was chosen as secretary for the meeting. All elections were unanimously chosen.
7. Approval of annual report for 2014
8. The Chairman of the meeting went through the annual report for 2014. The General Assembly took note of this and there were no comments to the report.
10. Approval of the income statement and balance sheet for 2014
11. The income statement and balance sheet for 2014 was presented for the holding company and the group to the general meeting by the chairman of the meeting. The general meeting took notice of the presentation and there were no comments to the presentation. The income statement for 2014 and balance sheet for 2014 for the holding company and the group were approved.
13. Allocation of profit for 2014
14. The profit for 2014 was TNOK 23.680 for the holding company. The Board of Directors suggested a dividend to the shareholders of NOK 1.40 per share, total TNOK 25.362 and that TNOK 1 682 is deducted from other equity. The company has 221.000 Medistim shares and does not pay dividend on own shares. Shareholders registered in VPS by the end of the 23rd of April 2015 will have the right to the dividend. The Board of director's suggestion was approved unanimously by the general assembly. The Medistim shares will be traded as ex dividend NOK 1.40 as of the 24th of April.
16. The Board of Director's declaration on salary and other remuneration to the management The chairman gave an orientation to the general meeting of the principals used to set salary and remuneration to the management and key personnel. The declaration is also described in the annual report. The general meeting took notice of the orientation and approved the principals for salary and remuneration to management and key personnel.
17. Approval of fee to the auditor
18. Fee to the auditor was in total TNOK 326 where TNOK 305 was for the audit and TNOK 21 was for other services. The fee to the auditor was approved by the general meeting.
20. Election of board members. Two of the board members are on election and one has withdrawn from position
21. Two of the board members, chairman Øyvin Brøymer and board member Siri Fürst, were on election for a new term of two years. The nomination committee recommends that both candidates are elected for a new term of two years. The candidates were unanimously elected, Øyvin Brøymer as chairman and Siri Fürst as board member for a two year term until ordinary general meeting in 2017.
23. Approval of fee to the Board of Director's
24. The fee to the Board of Director's in 2014 was NOK 250.000 to the chairman. Fee to the board members was NOK 150.000 to 4 members. Total fee for 2014 was NOK 850.000. The fee to the Board of Director's was approved by the general meeting.
26. Election of leader for the nomination committee
27. Two of the nomination committee members were on election. This was Asbjørn Buanes and Bjørn Henrik Rasmussen. Both were willing to take a new term and were re-elected for a new term of two years.
29. Approval of fee to the nomination committee
30. It was suggested to the General Meeting that the leader of the Nomination Committee was compensated with 15 TNOK and that the members were compensated with 10 TNOK. Total purposed fee to the Nomination Committee was 35 TNOK. The fee to the nomination committee was approved by the general meeting.
32. Approval of the Board of Director's suggestion to the general meeting to renew the Board of Director's authorisation to increase share capital.
33. The general meeting gave the Board of director's approval to increase share capital on the following terms and conditions:
35. The Board of Director's is authorised to increase share capital up to NOK 458,433.25 by issuing up to 1,833,733 new shares at par value of NOK 0.25. The share price and other terms when issuing new shares are set by the board of directors. The board of directors can increase the share capital once or in several different occasions.
36. In case of a change in par value of the share as a result of a split, fond emission or something similar, is the authorisation adjusted accordingly with the number of shares that can be issued. The share price and other terms are adjusted according to generally known principles for such adjustments, but always within the regulations in the Public Limited Companies Act.
37. The authorisation shall also include capital increase against other assets than cash deposits.
38. The shareholders preferential rights to subscribe shares can be set aside by the board according to the Public Limited Companies Act § 10-4.
39. The authorisation shall include a decision including a fusion according to Public Limited Companies Act § 13-5.
40. The authorisation is valid until the next ordinary general meeting.
1. The general meeting approved the Board of Director's authorisation to increase share capital unanimously according to the above terms and conditions.The general meetings resolution will be registered in the Brønnøysund register centre and must be registered before the Board of Directors can use the authorisation.
1. Approval of authorisation to purchase own shares
2. The general meeting gave the board of directors renewed power of attorney to purchase own shares on the following terms and conditions:
4. The authorisation is valid until the next general meeting.
5. The company can purchase shares at par value up to NOK 458,433.25, which are 1,833,733 shares at today's par value.
6. The highest price per share shall maximum be NOK 100.00 per share.
7. The lowest price per share shall minimum be NOK 0.25 per share.
8. The Board of Director's can freely decide how to purchase the shares as long as the principle for equal treatment is followed.
9. The general meeting approved the power of attorney to purchase own shares unanimously according to above terms and conditions.
1. The general meeting resolution must be registered in the Brønnøysund register centre before the board can use the authorisation.* * *There were no other issues on the agenda. The meeting was ended and the minutes signed.Oslo 23. April 2015Asbjørn Buanes Øyvin A. BrøymerSign. Sign.Attachment 1 to the general meetingOverview of participants at the general meeting in Medistim ASA the 23th of April 2015Total number of shares in Medistim ASA 18 116 336Shareholder Number of shares

Chr Salvesen & Chr. Thams	1 862 500	Through proxy	1 862 500	Øyvin Brøymer
Follum Capital	1 000 000	Through proxy	1 000 000	Øyvin Brøymer
Skagen Vekst Verdipapirfond	1 465 625	Through proxy	1 465 625	Kari Krogstad
Rigmor Blix	180 000
Intertrade Shipping	3 850 000
Asbjørn Buanes	928 436
Thomas Jakobsen	70 000
Kari Krogstad	55 000
Dyvi Invest AS

1. Totalt 9 411 561 4 328 125Represented 51,95 % Through proxy 23,89 %